氯化锂通过抑制小胶质细胞活化在脂多糖诱导的视网膜损伤中发挥抗炎和神经保护作用
本研究探索氯化锂(LiCl)在脂多糖(LPS)诱导的视网膜损伤中的抗炎与神经保护作用。体外实验显示LiCl减少小胶质细胞促炎因子产生、抑制形态学活化及NF-κB、Akt、PI3K磷酸化,并促进视网膜神经元存活、减少凋亡。体内内毒素诱导葡萄膜炎小鼠模型中,LiCl减少玻璃体腔炎性浸润细胞、视网膜促炎因子表达及小胶质细胞活化、增殖和迁移,减轻神经节细胞凋亡和视网膜水肿,并挽救视网膜功能损伤。结论认为LiCl通过PI3K/Akt/NF-κB通路抑制小胶质细胞活化发挥抗炎和神经保护作用,为治疗视网膜炎症性疾病提供新选择。
要点
- 体外LiCl减少LPS刺激的小胶质细胞促炎因子(iNOS、TNF-α、IL-6)产生并抑制形态学活化。
- 体内LiCl减少玻璃体腔炎性浸润细胞和视网膜促炎因子表达,抑制小胶质细胞活化、增殖和迁移。
- LiCl减轻LPS诱导的神经节细胞凋亡和视网膜水肿,并挽救视网膜功能损伤。
核心结论
- LiCl通过PI3K/Akt/NF-κB通路抑制小胶质细胞活化,在LPS诱导的视网膜损伤中发挥抗炎和神经保护作用。
- LiCl为治疗视网膜炎症性疾病提供了一种新颖且有前景的选择。
研究设计与样本
- 体外实验:原代视网膜小胶质细胞经LiCl预处理后予LPS刺激,检测促炎因子、形态变化及炎症相关信号通路。
- 体外实验:原代视网膜神经元与含或不含LiCl的小胶质细胞条件培养基共培养,评估神经毒性。
- 体内实验:建立内毒素诱导葡萄膜炎小鼠模型,每只动物腹腔注射LiCl或溶剂。
主要发现
- 体外LiCl对小胶质细胞无明显毒性作用,显著降低诱导型一氧化氮合酶、肿瘤坏死因子α、白细胞介素6产生,抑制形态学小胶质细胞活化,抑制NF-κB、Akt和PI3K磷酸化。
- 体外LiCl促进视网膜神经元存活,减少细胞凋亡和γ-H2AX表达。
- 体内LiCl减少玻璃体腔炎性浸润细胞,降低视网膜促炎细胞因子表达,抑制LPS诱导的小胶质细胞活化、增殖和迁移。
- 体内LiCl减少LPS诱导的神经节细胞凋亡和视网膜水肿,并挽救视网膜功能损伤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To explore the anti-inflammatory and neuroprotective effects of lithium chloride (LiCl) in LPS-induced retinal injury. METHODS: In vitro, primary retinal microglia were pretreated with LiCl and stimulated with lipopolysaccharide (LPS). Pro-inflammatory cytokine production, microglial morphological changes, and inflammation-associated signaling pathways were measured by real-time PCR (RT-PCR), western blotting, and immunofluorescence. Primary retinal neurons were cultured with microglial-derived conditioned medium in the absence or presence of LiCl. Neurotoxicity was evaluated by Cell Counting Kit-8 (CCK-8), terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay, and γ-H2AX detection. In vivo, an endotoxin-induced uveitis mice model was established, and each animal was given intraperitoneal injection of LiCl or vehicle. The retinal inflammatory response was measured by hematoxylin and eosin and fluorescent staining, RT-PCR, western blotting, and TUNEL assay. Retinal thickness and function were evaluated by spectral-domain optical coherence tomography and electroretinography. RESULTS: In vitro, LiCl exerted no obvious toxic effects on microglia and significantly decreased proinflammatory factor (inducible nitric oxide synthase, tumor necrosis factor α, interleukin 6) production, inhibited microglial activation in morphology, and suppressed nuclear factor kappa B (NF-κB), Akt, and phosphatidylinositol 3-kinase (PI3K) phosphorylation. Moreover, LiCl promoted retinal neuron survival and reduced cell apoptosis and the expression of γ-H2AX. In vivo, LiCl reduced inflammatory infiltrating cells in the vitreous cavity and decreased proinflammatory cytokine expression in retinas. LiCl suppressed LPS-induced microglial activation, proliferation, and migration. Additionally, LiCl reduced LPS-induced apoptosis of ganglion cells and retinal edema and rescued retinal functional damage. CONCLUSIONS: This study demonstrates that LiCl exerts anti-inflammatory and neuroprotective effects by inhibiting microglial activation via the PI3K/Akt/NF-κB pathway in LPS-induced retinal injury. LiCl provides a novel and promising option to treat retinal inflammatory diseases.
引用
- Wu N, Luo Q, Huang Y, et al. Lithium Chloride Exerts Anti-Inflammatory and Neuroprotective Effects by Inhibiting Microglial Activation in LPS-Induced Retinal Injury. Invest Ophthalmol Vis Sci. 2023. PMID: 37000125. doi:10.1167/iovs.64.3.35
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。